The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of …
The American Diabetes Association (ADA) and the European Association for the Study of
Diabetes (EASD) convened a writing group to develop a consensus statement on the …
Diabetes (EASD) convened a writing group to develop a consensus statement on the …
International consensus on use of continuous glucose monitoring
T Danne, R Nimri, T Battelino, RM Bergenstal… - Diabetes …, 2017 - Am Diabetes Assoc
Measurement of glycated hemoglobin (HbA1c) has been the traditional method for
assessing glycemic control. However, it does not reflect intra-and interday glycemic …
assessing glycemic control. However, it does not reflect intra-and interday glycemic …
Treatment of diabetes in older adults: an Endocrine Society clinical practice guideline
D LeRoith, GJ Biessels, SS Braithwaite… - The Journal of …, 2019 - academic.oup.com
Objective The objective is to formulate clinical practice guidelines for the treatment of
diabetes in older adults. Conclusions Diabetes, particularly type 2, is becoming more …
diabetes in older adults. Conclusions Diabetes, particularly type 2, is becoming more …
Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial
Importance Continuous glucose monitoring (CGM) provides real-time assessment of
glucose levels and may be beneficial in reducing hypoglycemia in older adults with type 1 …
glucose levels and may be beneficial in reducing hypoglycemia in older adults with type 1 …
Advances in technology for management of type 1 diabetes
RW Beck, RM Bergenstal, LM Laffel, JC Pickup - The Lancet, 2019 - thelancet.com
Technological advances have had a major effect on the management of type 1 diabetes. In
addition to blood glucose meters, devices used by people with type 1 diabetes include …
addition to blood glucose meters, devices used by people with type 1 diabetes include …
Current state of type 1 diabetes treatment in the US: updated data from the T1D Exchange clinic registry
KM Miller, NC Foster, RW Beck, RM Bergenstal… - Diabetes …, 2015 - Am Diabetes Assoc
To examine the overall state of metabolic control and current use of advanced diabetes
technologies in the US, we report recent data collected on individuals with type 1 diabetes …
technologies in the US, we report recent data collected on individuals with type 1 diabetes …
Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia
BJ Hering, WR Clarke, ND Bridges… - Diabetes …, 2016 - Am Diabetes Assoc
OBJECTIVE Impaired awareness of hypoglycemia (IAH) and severe hypoglycemic events
(SHEs) cause substantial morbidity and mortality in patients with type 1 diabetes (T1D) …
(SHEs) cause substantial morbidity and mortality in patients with type 1 diabetes (T1D) …
Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium–glucose cotransporter 2 inhibition
AL Peters, EO Buschur, JB Buse, P Cohan… - Diabetes …, 2015 - Am Diabetes Assoc
OBJECTIVE Sodium–glucose cotransporter 2 (SGLT-2) inhibitors are the most recently
approved antihyperglycemic medications. We sought to describe their association with …
approved antihyperglycemic medications. We sought to describe their association with …
Diabetic emergencies—ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia
G Umpierrez, M Korytkowski - Nature Reviews Endocrinology, 2016 - nature.com
Diabetic ketoacidosis (DKA), hyperglycaemic hyperosmolar state (HHS) and hypoglycaemia
are serious complications of diabetes mellitus that require prompt recognition, diagnosis and …
are serious complications of diabetes mellitus that require prompt recognition, diagnosis and …
Empagliflozin as adjunctive to insulin therapy in type 1 diabetes: the EASE trials
J Rosenstock, J Marquard, LM Laffel… - Diabetes …, 2018 - Am Diabetes Assoc
OBJECTIVE To evaluate the safety and efficacy of empagliflozin 10-and 25-mg doses plus a
unique lower dose (2.5 mg) as adjunct to intensified insulin in patients with type 1 diabetes …
unique lower dose (2.5 mg) as adjunct to intensified insulin in patients with type 1 diabetes …